Oncolytic virus atlas
All 119 oncolytic viruses in the registry, joined to their virus family, transgenes, the cancers their trials enrol, routes and shared sponsors. Those that share things sit near each other, so the field's clusters show up on their own. Click a dot to see what it connects to; drag to rearrange or pan; zoom with the + and − buttons, Ctrl-scroll or a pinch.
No confirmed trial (16)Early phase 1 / phase 1 (47)Phase 2 (42)Phase 3 (9)Approved (5)
Stage is the furthest a product has got: an approval anywhere, else the highest phase among its confirmed trials. Cancers come from those trials' conditions, grouped.
All oncolytic viruses
| Virus | Family | Stage | Transgenes | Route | Trials in |
|---|---|---|---|---|---|
| H101 (H101, Oncorine) | Adenoviridae | Approved | intratumoral, intra arterial, intraperitoneal | Colorectal, Head and neck, Liver, Lung, Melanoma, Mesothelioma, Pancreatic, Peritoneal, Solid tumours (any) | |
| Rigvir (Rigvir) | Picornaviridae | Approved | intramuscular | Melanoma | |
| talimogene laherparepvec (Imlygic, JS1 34.5-hGMCSF 47- pA-) | Orthoherpesviridae | Approved | CSF2 | intratumoral | Bladder, Blood cancers, Breast, Colorectal, Head and neck, Liver, Lung, Melanoma, Pancreatic, Peritoneal, Sarcoma, Solid tumours (any) |
| teserpaturev (DS-1647, Delytact, G47∆) | Orthoherpesviridae | Approved | LacZ | intratumoral, intracerebral | Glioma and brain |
| vusolimogene oderparepvec (RP1, Tudriqev) | Orthoherpesviridae | Approved | CSF2, GALV-GP R- | intratumoral | Breast, Lung, Melanoma, Sarcoma |
| BT-001 (BT-001, TG6030) | Poxviridae | Phase 3 | anti-CTLA-4 antibody (4-E03), CSF2 | intratumoral | Breast, Colorectal, Lung, Melanoma, Sarcoma, Solid tumours (any) |
| cretostimogene grenadenorepvec (CG0070) | Adenoviridae | Phase 3 | CSF2 | intravesical | Bladder |
| OH2 (OH2) | Orthoherpesviridae | Phase 4 | CSF2 | intratumoral, intravesical | Bladder, Colorectal, Glioma and brain, Liver, Melanoma, Pancreatic, Solid tumours (any) |
| olvimulogene nanivacirepvec (GLV-1h68, Olvi-Vec) | Poxviridae | Phase 3 | RUC-GFP, LacZ, gusA | intravenous, intraperitoneal, intrapleural, intratumoral | Blood cancers, Head and neck, Lung, Mesothelioma, Ovarian, Peritoneal, Solid tumours (any) |
| pelareorep (PO-BB0209, Reolysin) | Spinareoviridae | Phase 3 | intravenous, intratumoral | Bladder, Blood cancers, Breast, Colorectal, Glioma and brain, Head and neck, Lung, Melanoma, Ovarian, Pancreatic, Peritoneal, Prostate, Sarcoma, Solid tumours (any) | |
| pexastimogene devacirepvec (JX-594, TG-6006) | Poxviridae | Phase 3 | CSF2, LacZ | intratumoral, intravenous | Blood cancers, Breast, Colorectal, Head and neck, Kidney, Liver, Lung, Melanoma, Neuroblastoma, Ovarian, Sarcoma, Solid tumours (any) |
| sturlimogene erparepvec (RP2) | Orthoherpesviridae | Phase 3 | CSF2, GALV-GP R-, anti-CTLA-4 antibody | intratumoral | Colorectal, Gastric and oesophageal, Kidney, Liver, Melanoma, Solid tumours (any) |
| vocimagene amiretrorepvec (Toca 511) | Retroviridae | Phase 3 | yeast cytosine deaminase (CD) | intracerebral, intravenous | Bladder, Blood cancers, Breast, Colorectal, Glioma and brain, Head and neck, Lung, Melanoma, Ovarian, Pancreatic, Sarcoma, Solid tumours (any) |
| VRT106 (VRT106) | Togaviridae | Phase 3 | intratumoral | Gastric and oesophageal, Glioma and brain, Liver, Pancreatic, Solid tumours (any) | |
| AdAPT-001 (AdAPT-001) | Adenoviridae | Phase 2 | TGF-beta trap | intratumoral | Sarcoma, Solid tumours (any) |
| BioTTT001 (Ad-TD-nsIL12, BioTTT001) | Adenoviridae | Phase 2 | IL12A, IL12B (non-secreting) | intratumoral, intraperitoneal, intra arterial | Breast, Colorectal, Gastric and oesophageal, Glioma and brain, Solid tumours (any) |
| BS-006 (BS-006) | Orthoherpesviridae | Phase 2 | anti-PD-L1/CD3 bispecific antibody | intratumoral | Solid tumours (any) |
| canerpaturev (HF10, TBI-1401) | Orthoherpesviridae | Phase 2 | intratumoral, intradermal | Breast, Head and neck, Melanoma, Pancreatic, Solid tumours (any) | |
| CG7870 (CG7870) | Adenoviridae | Phase 2 | intratumoral, intravenous | Prostate | |
| delolimogene mupadenorepvec (LOAd703) | Adenoviridae | Phase 2 | CD40LG, TNFSF9 | intratumoral | Colorectal, Melanoma, Ovarian, Pancreatic |
| enadenotucirev | Adenoviridae | Phase 2 | intravenous, intratumoral, intraperitoneal | Bladder, Colorectal, Head and neck, Kidney, Lung, Ovarian, Solid tumours (any) | |
| G207 (G207) | Orthoherpesviridae | Phase 2 | LacZ | intratumoral, intracerebral | Glioma and brain, Solid tumours (any) |
| GC001 (GC001) | Poxviridae | Phase 2 | intratumoral | Breast, Colorectal, Gastric and oesophageal, Glioma and brain, Liver, Lung, Ovarian, Pancreatic, Sarcoma, Solid tumours (any) | |
| gebasaxturev (CAVATAK, V937) | Picornaviridae | Phase 2 | intratumoral, intravenous | Bladder, Breast, Head and neck, Liver, Lung, Melanoma, Prostate, Solid tumours (any) | |
| GM103 (GM103) | Adenoviridae | Phase 2 | intratumoral | Breast, Colorectal, Head and neck, Kidney, Melanoma, Solid tumours (any) | |
| HSV1716 (HSV1716, Seprehvir) | Orthoherpesviridae | Phase 2 | intratumoral, intracerebral, intravenous, intrapleural | Glioma and brain, Mesothelioma, Neuroblastoma, Sarcoma, Solid tumours (any) | |
| hV01 (hV01) | Poxviridae | Phase 2 | IL21 | Pancreatic, Solid tumours (any) | |
| ICOVIR-5 (ICOVIR-5) | Adenoviridae | Phase 2 | intravenous | Melanoma, Solid tumours (any) | |
| IDOV-SAFE (IDOV-SAFE) | Poxviridae | Phase 2 | intravenous | Solid tumours (any) | |
| igrelimogene litadenorepvec (Ad5/3-E2F-d24-hTNFa-IRES-hIL2, TILT-123) | Adenoviridae | Phase 2 | TNF, IL2 | intratumoral, intravenous, intraperitoneal | Head and neck, Lung, Melanoma, Ovarian, Peritoneal, Solid tumours (any) |
| Ixovex-1 (Ixovex-1) | Adenoviridae | Phase 2 | intratumoral | Head and neck, Solid tumours (any) | |
| lerapolturev (PVSRIPO) | Picornaviridae | Phase 2 | intratumoral | Bladder, Breast, Glioma and brain, Melanoma, Sarcoma, Solid tumours (any) | |
| M032 (M032) | Orthoherpesviridae | Phase 2 | IL12A, IL12B | intratumoral, intracerebral | Glioma and brain, Sarcoma |
| MG1-MAGEA3 (MG1-MAGEA3, MG1MA3) | Rhabdoviridae | Phase 2 | MAGEA3 | intravenous | Lung, Melanoma, Solid tumours (any) |
| MV-NIS (MV-NIS) | Paramyxoviridae | Phase 2 | SLC5A5 | intraperitoneal, intravenous | Bladder, Blood cancers, Breast, Glioma and brain, Head and neck, Lung, Mesothelioma, Ovarian, Peritoneal, Sarcoma |
| NV1020 (NV1020) | Orthoherpesviridae | Phase 2 | intra arterial | Colorectal, Liver, Solid tumours (any) | |
| ON-01 (ON-01) | Orthoherpesviridae | Phase 2 | cytosine deaminase (CD) | intracerebral | Glioma and brain |
| ONCOS-102 (ONCOS-102) | Adenoviridae | Phase 2 | CSF2 | intratumoral, intraperitoneal | Colorectal, Melanoma, Mesothelioma, Ovarian, Peritoneal, Prostate, Solid tumours (any) |
| ORCA-010 (ORCA-010) | Adenoviridae | Phase 2 | intratumoral | Prostate | |
| OrienX010 (OrienX010) | Orthoherpesviridae | Phase 2 | CSF2 | intratumoral | Liver, Lung, Melanoma, Pancreatic |
| OVV-01 (C045, OVV-01) | Rhabdoviridae | Phase 2 | NY-ESO-1 (CTAG1B) | intratumoral | Blood cancers, Sarcoma, Solid tumours (any) |
| ParvOryx (ParvOryx) | Parvoviridae | Phase 2 | intratumoral, intravenous, intracerebral | Glioma and brain, Pancreatic | |
| RP3 (RP3) | Orthoherpesviridae | Phase 2 | CD40LG, TNFSF9, GALV-GP R-, anti-CTLA-4 antibody | intratumoral | Colorectal, Head and neck, Solid tumours (any) |
| suratadenoturev (OBP-301, Telomelysin) | Adenoviridae | Phase 2 | intratumoral | Gastric and oesophageal, Head and neck, Liver, Melanoma, Solid tumours (any) | |
| SVV-001 (NTX-010, SVV-001) | Picornaviridae | Phase 2 | intravenous | Kidney, Lung, Neuroblastoma, Sarcoma, Solid tumours (any) | |
| T3011 (MVR-T3011, T3011) | Orthoherpesviridae | Phase 2 | IL12A, IL12B, anti-PD-1 antibody | intratumoral, intravenous, intra arterial | Bladder, Blood cancers, Breast, Colorectal, Gastric and oesophageal, Liver, Lung, Melanoma, Mesothelioma, Ovarian, Sarcoma, Solid tumours (any) |
| tasadenoturev (Ad5-Delta24RGD, DNX-2401) | Adenoviridae | Phase 2 | intratumoral, intracerebral | Glioma and brain, Melanoma, Ovarian, Peritoneal, Sarcoma | |
| TG6002 (T601, TG6002) | Poxviridae | Phase 2 | FCU1 | intravenous, intratumoral, intra arterial | Colorectal, Glioma and brain, Liver, Solid tumours (any) |
| THEO-260 (THEO-260) | Adenoviridae | Phase 2 | intraperitoneal | Ovarian | |
| VG161 (VG161) | Orthoherpesviridae | Phase 2 | IL12A, IL12B, IL15, IL15RA, PD-L1 blocking peptide | intratumoral | Bladder, Gastric and oesophageal, Liver, Pancreatic, Sarcoma, Solid tumours (any) |
| VG2025 (VG2025) | Orthoherpesviridae | Phase 2 | IL12A, IL12B, IL15, IL15RA | intratumoral | Liver, Solid tumours (any) |
| VSV-hIFNbeta (VSV-hIFNbeta) | Rhabdoviridae | Phase 2 | IFNB1 | intratumoral, intra arterial | Blood cancers, Kidney, Liver, Melanoma, Sarcoma, Solid tumours (any) |
| VSV-IFNbeta-NIS (VSV-hIFNbeta-NIS, Voyager-V1) | Rhabdoviridae | Phase 2 | IFNB1, SLC5A5 | intravenous | Blood cancers, Breast, Colorectal, Head and neck, Kidney, Lung, Melanoma, Sarcoma, Solid tumours (any) |
| YH-02 (YH-02) | Adenoviridae | Phase 2 | Solid tumours (any) | ||
| YSCH-01 (YSCH-01) | Adenoviridae | Phase 2 | interferon (L-IFN) | intratumoral | Bladder, Breast, Glioma and brain, Head and neck, Lung, Melanoma, Ovarian, Solid tumours (any) |
| zabilugene almadenorepvec (VCN-01) | Adenoviridae | Phase 2 | SPAM1 | intravenous, intratumoral, intravitreal | Head and neck, Ovarian, Pancreatic, Solid tumours (any) |
| Ad5-yCD/mutTK(SR39)rep-ADP (Ad5-yCD/mutTK(SR39)rep-ADP) | Adenoviridae | Phase 1 | yCD/mutTK(SR39) suicide-gene fusion, adenovirus death protein (ADP) | intratumoral | Glioma and brain, Lung |
| Ad5-yCD/mutTKSR39rep-hIL12 (Ad5-yCD/mutTKSR39rep-hIL12) | Adenoviridae | Phase 1 | yCD/mutTK(SR39) suicide-gene fusion, IL12A, IL12B | intratumoral | Pancreatic, Prostate |
| Adze1.C (Adze1.C) | Adenoviridae | Phase 1 | Melanoma | ||
| ASP9801 (ASP9801) | Poxviridae | Phase 1 | IL7, IL12A, IL12B | intratumoral | Solid tumours (any) |
| BI 1831169 (BI 1831169) | Rhabdoviridae | Phase 1 | intravenous, intratumoral | Solid tumours (any) | |
| C134 (C134) | Orthoherpesviridae | Phase 1 | HCMV IRS1 | intratumoral, intracerebral | Glioma and brain, Sarcoma |
| CAdVEC (CAdVEC) | Adenoviridae | Phase 1 | IL12A, IL12B, anti-PD-L1 mini-antibody | intratumoral | Bladder, Breast, Colorectal, Gastric and oesophageal, Head and neck, Lung, Pancreatic, Solid tumours (any) |
| CAN-3110 (CAN-3110, rQNestin34.5v.2) | Orthoherpesviridae | Phase 1 | GFP | intratumoral, intracerebral | Glioma and brain |
| CF33-CD19 (CF33-CD19, CF33-CD19t, onCARlytics) | Poxviridae | Phase 1 | CD19 (truncated) | intratumoral, intravenous | Solid tumours (any) |
| CF33-hNIS (CF33-hNIS, HOV2, VAXINIA) | Poxviridae | Phase 1 | SLC5A5 (hNIS) | intratumoral, intravenous | Breast, Solid tumours (any) |
| CF33-hNIS-antiPDL1 (CF33-hNIS-antiPDL1, CHECKvacc) | Poxviridae | Phase 1 | SLC5A5 (hNIS), anti-PD-L1 antibody | intratumoral | Breast |
| CRAd-S-pk7 (CRAd-S-pk7) | Adenoviridae | Phase 1 | intracerebral | Glioma and brain | |
| GO306 (GO306) | Poxviridae | Phase 1 | Solid tumours (any) | ||
| ICVB-1042 (ICVB-1042) | Adenoviridae | Phase 1 | YPet reporter protein | intratumoral, intravenous | Solid tumours (any) |
| IDOV-Immune (IDOV-Immune) | Poxviridae | Phase 1 | Bladder, Breast, Colorectal, Gastric and oesophageal, Head and neck, Kidney, Liver, Lung, Melanoma, Ovarian, Pancreatic, Prostate, Sarcoma, Solid tumours (any) | ||
| JNJ-87704916 (JNJ-87704916) | Orthoherpesviridae | Phase 1 | intratumoral | Solid tumours (any) | |
| JX-929 (JX-929, vvDD-CDSR) | Poxviridae | Phase 1 | cytosine deaminase, SSTR2 | intratumoral, intravenous | Breast, Colorectal, Head and neck, Liver, Melanoma, Pancreatic |
| KD01 (KD01) | Adenoviridae | Phase 1 | intratumoral | Bladder | |
| lontucirev (CI-1042, ONYX-015) | Adenoviridae | Phase 1 | intratumoral, intravenous, intra arterial, intraperitoneal | Head and neck | |
| M1-c6v1 (M1-c6v1) | Togaviridae | Phase 1 | intravenous | Liver, Solid tumours (any) | |
| MEDI5395 (MEDI5395) | Paramyxoviridae | Phase 1 | CSF2 | intravenous | Solid tumours (any) |
| MEM-288 (MEM-288) | Adenoviridae | Phase 1 | IFNB1, chimeric CD40 ligand (MEM40) | intratumoral | Breast, Head and neck, Lung, Melanoma, Pancreatic, Solid tumours (any) |
| MV-CEA (MV-CEA) | Paramyxoviridae | Phase 1 | CEACAM5 | intraperitoneal | Glioma and brain, Ovarian, Peritoneal |
| MV-s-NAP (MV-s-NAP) | Paramyxoviridae | Phase 1 | H. pylori NAP | intratumoral | Breast |
| MVR-C5252 (MVR-C5252) | Orthoherpesviridae | Phase 1 | IL12A, IL12B, anti-PD-1 antibody | intracerebral | Glioma and brain, Solid tumours (any) |
| NG-350A (NG-350A) | Adenoviridae | Phase 1 | anti-CD40 agonist antibody | intravenous, intratumoral | Colorectal, Pancreatic, Solid tumours (any) |
| NG-641 (NG-641) | Adenoviridae | Phase 1 | FAP-TAc bispecific T-cell activator, CXCL9, CXCL10, IFNA2 | intravenous, intratumoral | Head and neck, Solid tumours (any) |
| NRG-103 (NRG-103) | Adenoviridae | Phase 1 | Glioma and brain | ||
| ONCR-177 (ONCR-177) | Orthoherpesviridae | Phase 1 | IL12A, IL12B, CCL4, FLT3LG, anti-PD-1 antibody, anti-CTLA-4 antibody | intratumoral | Breast, Colorectal, Head and neck, Liver, Melanoma, Solid tumours (any) |
| OTS-412 (OTS-412) | Poxviridae | Phase 1 | Solid tumours (any) | ||
| PF-07263689 (PF-07263689) | Poxviridae | Phase 1 | Bladder, Colorectal, Head and neck, Kidney, Liver, Lung, Melanoma, Ovarian, Sarcoma, Solid tumours (any) | ||
| PV701 (PV701) | Paramyxoviridae | Phase 1 | intravenous | Head and neck, Peritoneal | |
| R130 (R130) | Orthoherpesviridae | Early phase 1 | Breast, Colorectal, Gastric and oesophageal, Glioma and brain, Head and neck, Kidney, Liver, Lung, Melanoma, Ovarian, Pancreatic, Peritoneal, Sarcoma, Solid tumours (any) | ||
| Revottack (Revottack) | Rhabdoviridae | Phase 1 | intravenous | Solid tumours (any) | |
| RGV005 (RGV005) | Poxviridae | Phase 1 | CAR (anti-CD19) | intratumoral, intravenous | Blood cancers, Liver |
| rRp450 (rRp450) | Orthoherpesviridae | Phase 1 | CYP2B1 (rat) | intra arterial | Liver |
| STI-1386 (STI-1386, Seprehvec) | Orthoherpesviridae | Phase 1 | anti-PD-1 scFv-Fc, TGFBR2 decoy, IL12A, IL12B | intravenous | Liver, Pancreatic, Sarcoma, Solid tumours (any) |
| SynOV1.1 (SynOV1.1) | Adenoviridae | Phase 1 | CSF2 | intratumoral | Liver |
| TBio-6517 (RIVAL-01, TBio-6517) | Poxviridae | Phase 1 | FLT3LG, anti-CTLA-4 antibody, IL12A, IL12B | intratumoral | Colorectal, Head and neck, Kidney, Melanoma, Mesothelioma, Solid tumours (any) |
| tezemlimogene daxadenorepvec (DNX-2440) | Adenoviridae | Phase 1 | TNFSF4 | intratumoral, intra arterial | Breast, Colorectal, Gastric and oesophageal, Glioma and brain, Kidney, Liver, Melanoma, Sarcoma |
| TG6050 (TG6050) | Poxviridae | Phase 1 | IL12A, IL12B, anti-CTLA-4 antibody | intravenous | Lung |
| TS-2021 (TS-2021) | Adenoviridae | Phase 1 | intratumoral | Glioma and brain | |
| VET3-TGI (VET3-TGI) | Poxviridae | Phase 1 | IL12A, IL12B, TGF-beta inhibitor | intravenous, intratumoral | Bladder, Colorectal, Head and neck, Kidney, Lung, Melanoma, Mesothelioma, Solid tumours (any) |
| VSV-02 (VSV-02) | Rhabdoviridae | Phase 1 | CD3/PD-L1 bispecific antibody | intravenous, intratumoral | Breast, Lung, Melanoma, Solid tumours (any) |
| VT-101 (VT-101) | Adenoviridae | Phase 1 | Bladder, Ovarian | ||
| VV-GMCSF-Lact (VV-GMCSF-Lact) | Poxviridae | Phase 1 | CSF2, lactaptin (RL2) | intratumoral | |
| vvDD-hIL2-RG-1 (vvDD-hIL2-RG-1) | Poxviridae | Phase 1 | IL2 (matrix-anchored) | intratumoral | Gastric and oesophageal, Liver, Peritoneal |
| Ad3-hTERT-E1A (Ad3-hTERT-E1A) | Adenoviridae | No confirmed trial | intratumoral, intraperitoneal, intrapleural, intravenous | ||
| Ad5-CD/TKrep (Ad5-CD/TKrep) | Adenoviridae | No confirmed trial | CD/HSV-1 TK suicide-gene fusion | intratumoral | |
| Ad5-D24-GMCSF (Ad5-D24-GMCSF) | Adenoviridae | No confirmed trial | CSF2 | intratumoral, intraperitoneal, intrapleural, intravenous | |
| Ad5-RGD-D24-GMCSF (Ad5-RGD-D24-GMCSF) | Adenoviridae | No confirmed trial | CSF2 | intratumoral, intraperitoneal, intrapleural, intravenous | |
| Ad5/3-Cox2L-D24 (Ad5/3-Cox2L-D24) | Adenoviridae | No confirmed trial | intratumoral, intraperitoneal, intrapleural, intravenous | ||
| Ad5/3-D24-hNIS (Ad5/3-D24-hNIS) | Adenoviridae | No confirmed trial | SLC5A5 | intratumoral, intraperitoneal, intrapleural, intravenous | |
| Ad5/3-E2F-d24-GMCSF (Ad5/3-E2F-d24-GMCSF) | Adenoviridae | No confirmed trial | CSF2 | intratumoral, intraperitoneal, intrapleural, intravenous | |
| Ad5/3-hTERT-E1A-hCD40L (Ad5/3-hTERT-E1A-hCD40L) | Adenoviridae | No confirmed trial | CD40LG | intratumoral, intraperitoneal, intrapleural, intravenous | |
| CG7060 (CG7060) | Adenoviridae | No confirmed trial | intratumoral | ||
| H103 (H103) | Adenoviridae | No confirmed trial | HSP70 | intratumoral | |
| ICOVIR-7 (ICOVIR-7) | Adenoviridae | No confirmed trial | intratumoral | ||
| KH901 (KH901) | Adenoviridae | No confirmed trial | CSF2 | intratumoral | |
| MTH-68/H (MTH-68/H) | Paramyxoviridae | No confirmed trial | intravenous | ||
| mumps virus (Asada series) | Paramyxoviridae | No confirmed trial | |||
| NDV-HUJ (NDV-HUJ) | Paramyxoviridae | No confirmed trial | intravenous | ||
| West Nile virus Egypt 101 | Flaviviridae | No confirmed trial | intravenous, intratumoral |